RecruitingNCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Sponsor
University of Pittsburgh
Enrollment
200 participants
Start Date
Oct 1, 2004
Study Type
OBSERVATIONAL
Conditions
Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- or older
- able and willing to provide informed consent
- diagnosed with CTCL
- diagnosed with either atopic dermatitis or eczema
Exclusion Criteria1
- Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Interventions
OTHERBlood draw, skin biopsy or urine collection
Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00177268
Related Trials
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
NCT065084632 locations
The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
NCT074675641 location
A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
NCT070554771 location
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
NCT052963043 locations
Prospective Longitudinal Observational Research in Atopic Dermatitis
NCT042405221 location